GGrantIndex
Sort

130,381 grants matching hiv

University of Rochester Center for AIDS Research

$1,544,856
Stephen Dewhurst · University Of Rochester · P30 · FY2017 · AI

Research Capacity Core

$1,544,855
Josiah Ochieng · Meharry Medical College · U54 · FY2022 · MD

HOPE in Action: A clinical trial of HIV-to-HIV deceased donor kidney transplantation

$1,544,393
Christine Marie Durand · Johns Hopkins University · U01 · FY2019 · AI

Addressing risk through Community Treatment for Infectious disease and Opioid use disorder Now (ACTION) among justice-involved populations

$1,544,013
Sandra Ann Springer · Yale University · U01 · FY2020 · DA

Host Defense Against HIV-related Pulmonary Infections

$1,543,865
Louisiana State Univ Hsc New Orleans · P01 · FY2004 · HL

MIAMI ADULT AIDS CLINICAL TRIALS GROUP, AACTG

$1,543,843
University Of Miami School Of Medicine · U01 · FY2000 · AI

PS12-1201 COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS

$1,543,753
Courtney Hampton · Arkansas State Department Of Health · U62 · FY2014 · PS

Johns Hopkins HIV Clinical Cohort

$1,543,732
Richard Douglas Moore · Johns Hopkins University · U01 · FY2024 · DA

United States Military HIV Research Program (MHRP) Clinical Trials Unit

$1,543,614
Robert A. Gramzinski · Walter Reed Army Institute Of Research · UM1 · FY2018 · AI

Novel anti-HIV carrageenan-based on microbicides

$1,543,420
Population Council · P01 · FY2004 · HD

ADULT AIDS CLINICAL TRIALS UNIT

$1,543,278
Duke University · U01 · FY2004 · AI

GH11-1151, S. Africa: HIV PREVENTION SERVICES, CAPACITY BUILDING ASSISTANCE AND EVALUATION ACTIVITIES F

$1,543,189
Harry Peter Hausler · Tb Hiv Care · U2G · FY2016 · GH

POTENTIAL FOR ENVIRONMENTAL AND THERAPEUTIC AGENTS TO INDUCE IMMUNOTOXICITY

$1,543,099
Kimber White · Virginia Commonwealth University · N01 · FY2010 · ES

Functional Genomics Laboratory (FGL)

$1,542,975
Anton Simeonov · National Center For Advancing Translational Sciences · ZIC · FY2023 · TR

ADULT AIDS CLINICAL TRIALS UNIT (ACTU)

$1,542,920
University Of Southern California · U01 · FY2002 · AI

GH11-1150: PROVISION OF MEDICAL MALE CIRCUMSION FOR HIV PREVENTION

$1,542,680
Kelly Curran · Johns Hopkins University · U2G · FY2014 · GH

Ancillary Studies of NAFLD and NASH in HIV infected Adults

$1,542,615
Naga P. Chalasani · Indiana University Indianapolis · R01 · FY2023 · DK

Immune correlates of protection

$1,542,573
Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI

Adjuvant development within the context of a vaccine to protect against B. pertussis

$1,542,270
Tulane University Of Louisiana · N01 · FY2018 · AI

ENHANCED COMPREHENSIVE HIV PREVENTION PLANN (ECHPP) ACTIVITIES FOR ATLANTA MSA

$1,542,206
William Lyons · Georgia Department Of Community Health · U65 · FY2011 · PS

Immunological Strategies to Modulate SIV Rebound Following ART Interruption

$1,541,832
Michael R Betts · University Of Pennsylvania · P01 · FY2019 · AI

PS12-1201 COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS

$1,541,700
Seema Dixit · Rhode Island State Dept Of Health · U62 · FY2015 · PS

Adjuvant discovery for vaccines against West Nile Virus and Influenza

$1,541,329
Herman Staats · Duke University · N01 · FY2016 · AI

Non Human Primate Core

$1,541,319
Michael K Axthelm · Oregon Health & Science University · P01 · FY2025 · AI

U of Colorado Center for AIDS Research

$1,541,289
University Of Colorado Denver · P30 · FY2004 · AI